Recent advancements in pharmacological strategies to modulate energy balance for combating obesity

The prevalence of obesity along with its related metabolic diseases has increased globally in recent decades. Obesity originates from a heterogeneous physiological state, which is further complicated by the influence of factors such as genetic, behavioural, and environmental. Lifestyle interventions...

Full description

Saved in:
Bibliographic Details
Published inMedChemComm Vol. 14; no. 8; pp. 1429 - 1445
Main Authors Pati, Benudhara, Sendh, Satyabrata, Sahu, Bijayashree, Pani, Sunil, Jena, Nivedita, Bal, Naresh Chandra
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 16.08.2023
RSC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The prevalence of obesity along with its related metabolic diseases has increased globally in recent decades. Obesity originates from a heterogeneous physiological state, which is further complicated by the influence of factors such as genetic, behavioural, and environmental. Lifestyle interventions including exercise and diet have limited success, necessitating the development of pharmacological approaches. Mechanistically, strategies target either reducing energy intake or increasing consumption through metabolism boosting. Current drugs lower energy intake via inducing satiety or inhibiting substrate absorption, while targeting mitochondria or cytosolic energy sensors has shown limited success due to toxicity. Nonshivering thermogenesis (NST) has provided hope for activating these processes selectively without significant side effects. The internet-based marketing of plant-based formulations for enhancing metabolism has surged. This review compiles scientific articles, magazines, newspapers, and online resources on anti-obesity drug development. Combination therapy of metabolic boosters and established anti-obesity compounds appears to be a promising future approach that requires further research. The prevalence of obesity along with its related metabolic diseases has increased globally in recent decades.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:2632-8682
2040-2503
2632-8682
2040-2511
DOI:10.1039/d3md00107e